2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 29, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 29, 2025 -- The prevalence of lifetime and past-year use of psilocybin increased from 2019 to 2023 among all age groups in the United States, according to a study published online April 22 in the Annals of Internal Medicine.

Karilynn M. Rockhill, Ph.D., M.P.H., from Denver Health and Hospital Authority, and colleagues quantified changes in prevalence and health care utilization of psilocybin users between 2014 and 2023 in a study using five nationally representative datasets.

The researchers found that before 2019, psilocybin use was relatively stable across datasets. Among adults (aged 18 years and older), lifetime use increased from 10.0 to 12.1 percent from 2019 to 2023 (25 to 31 million in the National Survey on Drug Use and Health dataset). Among adolescents aged 12 to 17 years, lifetime use increased from 1.1 to 1.3 percent from 2019 to 2023 (from 285,000 to 344,000 in the National Survey on Drug Use and Health dataset). Past-year psilocybin use increased 44 and 188 percent among young adults (18 to 29 years) and older adults (30 years and older), respectively, from 2019. The prevalence of past-year use was 2.1 percent among all adults in 2023, but varied by age group, ranging from 3.5 percent among young adults to 1.8 percent among older adults. Compared with nonusers, adults who used psilocybin in 2023 were younger and more likely to be male.

"Psilocybin use in the United States is increasing, and public health and health care professionals should consider these rising rates in policy and intervention development," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-04-30 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords